RAGE: A potential therapeutic target during FGF1 treatment of diabetes‐mediated liver injury-Reference-Cited by-全球学者库

RAGE: A potential therapeutic target during FGF1 treatment of diabetes‐mediated liver injury

Published:2021-03-31 Issue: Volume: Page:
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Zheng Peipei¹²,Tang Zonghao³,Xiong Jun¹^ORCID,Wang Beini¹,Xu Jingyu²,Chen Lulu¹,Cai Shufang²,Wu Chengbiao⁴,Ye Libing¹,Xu Ke²^ORCID,Chen Zimiao¹,Wu Yanqing²^ORCID,Xiao Jian¹^ORCID

Affiliation:

1. Department of Endocrinology The First Affiliated Hospital and School of Pharmaceutical Sciences Wenzhou Medical University Wenzhou China

2. The Institute of Life Sciences Wenzhou University Wenzhou China

3. Key Laboratory of Medical Electrophysiology of Ministry of Education Drug Discovery Research Center Southwest Medical University Luzhou China

4. Clinical Research Center Affiliated Xiangshan Hospital Wenzhou Medical University Wenzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16446

Reference42 articles.

1. In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes;Lee CH;J Diabetes Investig,2020

2. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus;Targher G;Nat Rev Endocrinol,2018

3. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis;Anstee QM;Nat Rev Gastroenterol Hepatol,2013

4. Role of advanced glycation end products in cellular signaling;Ott C;Redox Biol,2014

5. Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathway;Hou X;Cardiovasc Diabetol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validation;Nutrition & Metabolism;2023-11-23

2. Scutellarin alleviates liver injury in type 2 diabetic mellitus by suppressing hepatocyte apoptosis in vitro and in vivo;Chinese Herbal Medicines;2023-10

3. RAGE signaling regulates the progression of diabetic complications;Frontiers in Pharmacology;2023-03-16

4. Advances in FGFs for diabetes care applications;Life Sciences;2022-12

5. Paeoniflorin ameliorates diabetic liver injury by targeting the TXNIP-mediated NLRP3 inflammasome in db/db mice;International Immunopharmacology;2022-08